Richard Sima

1 week ago | sandiegouniontribune.com | Richard Sima

By Richard SimaThe Washington PostFive years since the pandemic began, millions of people are still grappling with long COVID, even as new patients are joining their ranks. “Considering how far along we are and how tens of millions of people are suffering, we’ve done very little,” said Eric Topol, a professor of translational medicine and the executive vice president of Scripps Research.

1 week ago | smh.com.au | Teddy Amenabar |Richard Sima

By Teddy Amenabar and Richard Sima May 25, 2025 — 11.09am, register or subscribe to save articles for later. Add articles to your saved list and come back to them any time. Billy Joel has cancelled all of his scheduled performances in the United States and Britain because of a brain disorder called normal pressure hydrocephalus, according to a statement posted Saturday on the singer’s social media accounts.

1 week ago | watoday.com.au | Teddy Amenabar |Richard Sima

People with normal pressure hydrocephalus may walk with a slow shuffle as if their feet are stuck to the floor, and they may have difficulty turning corners. “Usually, the gait disability is pretty severe to the point where they’re falling, and they’re hitting their head,” Yaeger said. In many cases, the normal pressure hydrocephalus is idiopathic, meaning the cause is unknown. The condition is rare but becomes more common with age.

1 week ago | washingtonpost.com | Teddy Amenabar |Richard Sima

Billy Joel cancels shows due to a brain disorder. Here’s what to know. (washingtonpost.com) Billy Joel cancels shows due to a brain disorder. Here’s what to know. By Teddy Amenabar; Richard Sima 2025052323572400 Billy Joel has canceled all of his scheduled performances in the United States and Britain because of a brain disorder called normal pressure hydrocephalus, according to a statement posted Friday on the singer's social media accounts.

2 weeks ago | unionleader.com | Richard Sima

Five years since the pandemic began, millions of people are still grappling with long COVID, even as new patients are joining their ranks. “Considering how far along we are and how tens of millions of people are suffering, we’ve done very little,” said Eric Topol, a professor of translational medicine and the executive vice president of Scripps Research. But researchers are pressing ahead with new clinical trials for more targeted treatments built on advances in our understanding of long COVID.